An alternative possibility is that all of the PM-Mito cases in the study by Temiz et al. had clinical features of IBM; our PM-COX cases that met “probable IBM” ENMC criteria also showed high degree of LC3 immunopositivity (open symbols in Figure 4a; see below for further discussion). Here, MAP1LC3A is linked to inclusion body myositis.